NDC 67457-913

Ultiva

Remifentanil Hydrochloride

Ultiva is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Llc. The primary component is Remifentanil Hydrochloride.

• Product ID: 67457-913_2ac37216-2e99-4d7b-b377-28444236702b
• NDC: 67457-913
• Product Type: Human Prescription Drug
• Proprietary Name: Ultiva
• Generic Name: Remifentanil Hydrochloride
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2020-04-15
• Marketing Category: NDA / NDA
• Application Number: NDA020630
• Labeler Name: Mylan Institutional LLC
• Substance Name: REMIFENTANIL HYDROCHLORIDE
• Active Ingredient Strength: 1 mg/mL
• Pharm Classes: Full Opioid Agonists [MoA],Opioid Agonist [EPC]
• DEA Schedule: CII
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 67457-913-02

10 VIAL, GLASS in 1 CARTON (67457-913-02) > 5 mL in 1 VIAL, GLASS (67457-913-00)

• Marketing Start Date: 2020-04-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Ultiva" or generic name "Remifentanil Hydrochloride"

NDC	Brand Name	Generic Name
67457-198	Ultiva	Remifentanil Hydrochloride
67457-912	Ultiva	Remifentanil Hydrochloride
67457-913	Ultiva	Remifentanil Hydrochloride
67457-914	Ultiva	Remifentanil Hydrochloride
0143-9391	REMIFENTANIL HYDROCHLORIDE	REMIFENTANIL HYDROCHLORIDE
0143-9392	REMIFENTANIL HYDROCHLORIDE	REMIFENTANIL HYDROCHLORIDE
0143-9393	REMIFENTANIL HYDROCHLORIDE	REMIFENTANIL HYDROCHLORIDE
63323-723	Remifentanil Hydrochloride	Remifentanil Hydrochloride
63323-724	Remifentanil Hydrochloride	Remifentanil Hydrochloride
63323-725	Remifentanil Hydrochloride	Remifentanil Hydrochloride
68475-505	REMIFENTANIL HYDROCHLORIDE	REMIFENTANIL HYDROCHLORIDE
68475-506	REMIFENTANIL HYDROCHLORIDE	REMIFENTANIL HYDROCHLORIDE
68475-507	REMIFENTANIL HYDROCHLORIDE	REMIFENTANIL HYDROCHLORIDE